
COVAXX, a unit of privately-owned United Biomedical Inc, plans to pursue mid- and late-stage trials for the vaccine candidate from early 2021 in Asia, Latin America and the United States.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3rA4nnA
via
IFTTT
0 comments:
Post a Comment